Cas no 51288-04-1 (4-Iodo-1H-benzimidazole)

4-Iodo-1H-benzimidazole structure
4-Iodo-1H-benzimidazole structure
Product Name:4-Iodo-1H-benzimidazole
CAS No:51288-04-1
MF:C7H5IN2
MW:244.032473325729
MDL:MFCD09910322
CID:55972
PubChem ID:21099512
Update Time:2025-08-05

4-Iodo-1H-benzimidazole Chemical and Physical Properties

Names and Identifiers

    • 4-Iodo-1H-benzo[d]imidazole
    • 4-Iodo-1H-benzimidazole
    • 4-Iodobenzimidazole
    • 7-Iodo-1H-benzimidazole
    • 1H-Benzimidazole,7-iodo
    • 4-iodo-1(3)H-benzimidazole
    • 4-Jod-benzimidazol
    • PS-11815
    • A904328
    • 7-iodo-1H-1,3-benzodiazole
    • EN300-3183520
    • AS-813/43501689
    • 1H-BenziMidazole, 7-iodo-
    • SCHEMBL3171067
    • DTXSID30610752
    • AC-27147
    • MOYBHUHLLQSMNP-UHFFFAOYSA-N
    • 51288-04-1
    • AKOS016003400
    • FT-0731586
    • MFCD09910322
    • DA-17137
    • G50349
    • benzimidazole, 4(7)-iodo-
    • MDL: MFCD09910322
    • Inchi: 1S/C7H5IN2/c8-5-2-1-3-6-7(5)10-4-9-6/h1-4H,(H,9,10)
    • InChI Key: MOYBHUHLLQSMNP-UHFFFAOYSA-N
    • SMILES: IC1=CC=CC2=C1N=CN2

Computed Properties

  • Exact Mass: 243.95000
  • Monoisotopic Mass: 243.95
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 10
  • Rotatable Bond Count: 0
  • Complexity: 129
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • Tautomer Count: 2
  • XLogP3: 2.1
  • Topological Polar Surface Area: 28.7A^2

Experimental Properties

  • Density: 2.082
  • Boiling Point: 438.5°C at 760 mmHg
  • Flash Point: 219°C
  • Refractive Index: 1.787
  • PSA: 28.68000
  • LogP: 2.16750

4-Iodo-1H-benzimidazole Customs Data

  • HS CODE:2933990090
  • Customs Data:

    China Customs Code:

    2933990090

    Overview:

    2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-Iodo-1H-benzimidazole Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM160739-1g
4-Iodo-1H-benzo[d]imidazole
51288-04-1 95%
1g
$691 2021-06-17
Chemenu
CM160739-5g
4-Iodo-1H-benzo[d]imidazole
51288-04-1 95%
5g
$1644 2021-06-17
Apollo Scientific
OR61441-250mg
4-Iodo-1H-benzimidazole
51288-04-1 95%
250mg
£80.00 2025-02-20
Apollo Scientific
OR61441-1g
4-Iodo-1H-benzimidazole
51288-04-1 95%
1g
£260.00 2025-02-20
abcr
AB531864-250 mg
4-Iodo-1H-benzimidazole; .
51288-04-1
250MG
€253.60 2023-07-10
abcr
AB531864-1 g
4-Iodo-1H-benzimidazole; .
51288-04-1
1g
€538.40 2023-07-10
Chemenu
CM160739-1g
4-Iodo-1H-benzo[d]imidazole
51288-04-1 95%
1g
$*** 2023-05-30
TRC
I719640-10mg
4-Iodo-1H-benzimidazole
51288-04-1
10mg
$ 50.00 2022-06-04
TRC
I719640-50mg
4-Iodo-1H-benzimidazole
51288-04-1
50mg
$ 115.00 2022-06-04
TRC
I719640-100mg
4-Iodo-1H-benzimidazole
51288-04-1
100mg
$ 185.00 2022-06-04
Recommended suppliers
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
Inner Mongolia Xinhong Biological Technology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Inner Mongolia Xinhong Biological Technology Co., Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.